The associated proteins and biological pathways identified represent insights into the underlying molecular mechanism of T2D and may serve as potential biomarkers for risk prediction and prevention for T2D.
Abstract
Type 2 diabetes (T2D) is a multifactorial metabolic disorder with an increasing global prevalence and significant health burdens. Early identification of individuals at high risk is crucial for timely intervention and prevention of T2D and complications. This study aims to investigate the association between the blood plasma proteome and T2D, identify protein biomarkers associated with incident T2D, and explore the underlying biological pathways involved in the disease development in the Trondelag Health Study (HUNT). The HUNT Study is a population-based cohort with four waves of enrolment beginning in 1984. Samples from HUNT3 were analysed with SomaScan including 3,221 using SomaScanv4.0 (HUNT-Soma5k, ~5,000 proteins) and 2,181 on SomaScanv4.1 (HUNT-Soma7k, ~7,000 proteins). We performed logistic regression and least absolute shrinkage and selection operator (LASSO) to generate the protein risk scores, and gene set enrichment analysis (GSEA) to identify potential biological pathways for incident T2D. We identified 313 (308 proteins) and 142 (128 proteins) aptamers that are significantly associated with incident T2D, in HUNT-Soma5k and HUNT-Soma7k, respectively. In HUNT-Soma5k, MXRA8 has strongest association with decreased risk and PLXB2 has strongest association with increased risk; while IGFBP2 has strongest association with decreased risk and INHBC has strongest association with increased risk for incident T2D in HUNT-Soma7k. The most significant pathway from GO Biological Process is organic acid metabolic process in both datasets. The associated proteins and biological pathways identified represent insights into the underlying molecular mechanism of T2D and may serve as potential biomarkers for risk prediction and prevention for T2D.
In participants with T2D and LFI, adding a metabolomic signature to SCORE2-Diabetes produced a statistically significant but moderate improvement in risk discrimination, which supports further evaluation in independent cohorts and prospective impact studies.
Mei-Li Li, Yan-Yan Shen, You-Wei Huang et al.· Frontiers in Endocrinology· 0 citations
Results indicate that CTSG and LTF may serve as promising diagnostic biomarkers for T1DM, and functional enrichment analysis showed that immune activation played an important role in T1DM.
Jia-Ci Li, Shu-Yue Zhang, Xue-Tao Wang et al.· PeerJ· 0 citations
Most polygenic scores (PS) for type 1 diabetes were developed using European (EUR) ancestry datasets, limiting performance in non-European (non-EUR) populations. We evaluated novel type 1 diabetes PS across diverse populations to assess whether newer models improve prediction in underrepresented populations. Seven type...
Stella Nam, R. Kreienkamp, Jiang Li et al.· medRxiv· 0 citations
This study identified novel T2DM-associated plasma biomarkers and established a robust three-protein signature (VSIG2, S100A11, S100A5) for age stratification and biological senescence evaluation in T2DM.
Yan Yang, Shi-Yu Liu, Chun-Guang Xie et al.· Frontiers in Endocrinology· 0 citations
Background The purpose of this study was to investigate genetic risk factors associated with ischemic heart disease (IHD) in Russian adults, to develop prognostic PRS models for IHD risk stratification, and to gain a better understanding of molecular mechanisms underlying IHD through a transcriptome analysis. Materials...
Veronika Daniel, Наталья Георгиевна Романова, A. Mamchur et al.· Frontiers in Cardiovascular...· 0 citations
The authors' study identified putative actionable proteins that could reduce the elevated T2D risk attributable to childhood adiposity in Europeans, but their relevance in Asian populations requires further investigation.
Siyu Chen, Yiwen Liang, Shan Luo et al.· International Journal of Epi...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.